healthcarenewsblogs

  Dercum’s disease is a rare pain syndrome characterized by chronically painful growths of fatty tissue or lipomas. These lipomas most commonly occur in the upper arms, upper legs, and trunk region. According to a report by the American Society of Interventional Pain Physicians in 2017, although women are most commonly affected by this condition, about 16% of the reported cases were in men. The common symptoms of this condition include painful fatty lipomas covering the body, obesity majorly in women in menopausal age, weakness, memory issues, elevated heart rate, joint aches, depression, and dementia. Currently, there is no cure for this condition and it is treated symptomatically with surgery, alternative therapies, and with medications such as non-steroidal anti-inflammatory drugs, diuretics, among others. The global dercum’s disease market is anticipated to be growing due to factors such increasing expenditures in the healthcare sector in the developed as well as developing econ

  Market Research Future (MRFR) studied the global overactive bladder treatment market 2021 in the review period .As per MRFR daat, the overactive bladder treatment market is expected to thrive at 3.1% CAGR during the forecast tenure, the global overactive bladder treatment market is expected to earn decent value. Market Drivers and Restraints The rise in the number of patients with urinary urgency and high frequency, and nocturia; typically diagnosed with overactive bladder (OAB) can boost the need for effective treatment. The rise in occurrences of neurological diseases, especially among the growing geriatric group, can prompt the need for OAB management that can support the expansion of the global OAB market in the assessment period. In addition, upgradation and innovations of intravesical therapies and rapid commercialization of such new launches by pharma companies can prompt the market rise in the assessment tenure. On the other hand, issues with funding new solutions and

  The uptick in demand for nanotechnology practices that can solve several genetic-related diseases has increased of late. The Multiplex Assays Market is anticipated to progress with a CAGR of 7.8% during the forecast period. The market for multiplex arrays is advancing due to the increased funding and research being diverted to the market. Increased awareness of the benefits of multiplex assays is fuelling the growth of the market over the forecast period. The multifactorial nature of several diseases and pathological conditions such as Alzheimer and cancer are motivating the development of the market significantly. Competitive Analysis The availability of a good labor force along with assets is influencing to the general market advancement. The external factors that are motivating the market expansion which is dependent on the practices and the strategic roadmaps that are exploited by market players. The alteration in the quality of products and services is the chief factor is g

  The urethral stricture market is expected to grow at a 7.30% CAGR, along with a market valuation worth USD 1.53 billion. Urethral stricture is a chronic disease which can narrow the urethral opening due to injuries, scars, genetic disorders and sexually transmitted diseases. This can restrict urine flow and be a major cause of various urological disorders. The urethral stricture market is expanding steadily due to the rise in the treatment of injuries, kidney stones, poor dietary habits, obesity, and other medical conditions that require urethral stents, dilators, and catheters. Apart from this, improving healthcare facilities and growing awareness about the disease and treatment positively affect the market size globally. Surgeries like urethral dilations are popular in countries like India and China due to their high efficiency and low cost. Furthermore, the introduction of new and advanced medications and treatments is likely to boost the market growth during the forecast perio

  The US dietary supplements market is expected to grow at a CAGR of 8.45% during the forecast period 2020-2030. The dietary supplement market is governed by specialty ingredients to meet the consumer needs for nutritional supplements. Specialty ingredients mainly include vitamins, herbs, botanicals, meal supplements, amino acids, enzymes and others. In an average, adults in U.S. take one or more supplements daily or occasionally. According to Office of Dietary supplement’s National Institutes of Health, the popular supplements include Vitamin D and E, plant nutrition products such as garlic and echinacea, specialty products like fish oils, glucosamine , nutritional supplements and probiotics. Growing prevalence of chronic diseases like cardiovascular, cancer owing to fluctuating diet and inactive lifestyle in adults is expected to promote rise in dietary supplement market in United States. Moreover, the rapid advancements in dietary supplements manufacturing in personalized nutrit

  Autoimmune disease is a medical condition that causes abnormalities in the immune response and triggers damage to the healthy body tissues. The increasing prevalence of autoimmune diseases all over the world is generating high demand for effective treatments in the global market. As per the report published by Market Research Future (MRFR), the global autoimmune disease treatment market is anticipated to expand remarkably at a noteworthy CAGR of 11.2% during the forecast period. Key Players: The key players of the global autoimmune disease treatment market that rea profiled in the report published by MRFR are Abbott Laboratories, Amgen Inc., Genentech Inc., Bayer Schering Pharma AG, Biogen Idec Inc., Bio-Rad, Chugai Pharmaceutical Co. Ltd., Danaher, Elan Corporation Plc, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, HYCOR Biomedical, Johnson & Johnson Inc., Merck & Co. Inc., Siemens, Squibb Company, Thermo Fisher Scientific, and others. Market Dr

  Biomarkers discovery has become crucial as these play a key role in the early diagnosis of cancer, which increases the survival rates by enabling an early treatment. Clinical trials use metabolomics, imaging, and other innovative technologies to trace oncology biomarkers using proteins and genes. A cancer biomarker is indicative of the presence of cancer in the body. A biomarker can be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Cancer Biomarker Market at a CAGR of 15.8% During Forecasted Period, 2017-2023These biomarkers are thus increasing the chances of survival rates of patients and thus driving this market. Enhanced accuracy and speed of diagnosis and boost in government and private funds for biomarker research and drug discovery are also some of the drivers of this market. The growth of this market is backed by the increasing prevalence of cancer, rising investment in oncology research, technological advancement, increasing us

  Rising level of sugar intake by individuals is intensifying the cases diagnosed with root canal problems. Market reports connected with the healthcare industry have been made accessible by Market Research Future who publishes reports on other sectors that have been recently put out along with a report on this industry. The Root Canal Market is anticipated to earn USD 21.0 billion while expanding at a CAGR of 8% over the forecast period. The inclusion of some level of sweetness in products ranging from food, beverage and medicines especially cough syrups is increasing the requirement for root canals globally. The escalating population level worldwide is aiding the market growth for root canals substantially. Furthermore, the rising level of disposable income level is projected to power the growth of the market over the forecast period. Segmental Analysis The market for root canal has been segmented on the basis of drugs, types, devices, and end user. By types, the market has be

  According to MRFR analysis, the global vitrectomy devices market is expected to register a CAGR of ~6.5% from 2021 to 2030 and hold a value of ~USD 1,900 million by 2028. The global vitrectomy devices market is driven by several factors, such as the increased occurrence of diabetes worldwide, rising awareness among the population, growing demand for non-invasive techniques, and booming aging population. Furthermore, the market players are engaged in research and development activities around the globe. The industry players are focusing on the development of technologically advanced devices for better accuracy in surgery. The vitrectomy devices are the devices used for performing a vitrectomy procedure. These devices allow the surgeon to carry out the surgery efficiently with low invasion. The surgery is concluded with safety and ideal results, using vitrectomy surgery equipment, such as vitrectomy supplies, vitrectomy machine and systems. The commonly used vitrectomy devices ar

  Global Sleep Apnea Device Market is expected to have a market value of USD 7,683.72 Million by 2027. In sleep apnea, a person's breathing is interrupted in sleep. Untreated sleep apnea can cause chronic disorders, such as high blood pressure, cardiovascular diseases, obesity, and neurological conditions. Segment Analysis Global Sleep Apnea Device Market has been segmented into Type and End User. The global sleep apnea device market, by type, has been segmented into therapeutic diagnostic device, and sleep apnea monitoring devices . Based on therapeutic device, the market has been segmented into positive airway pressure devices, facial interfaces, accessories, oral appliances, adaptive servo-ventilators, surgical devices. Positive airway pressure devices is further classified as automatic positive airway pressure devices, bilevel positive airway pressure devices and continuous positive airway pressure devices. The facial interface type is further segmented into full-face ma